Integrated Services

Huayi Pharmaceuticals offers an integrated service for product development with our partners Weida Clinical Research and Velocyte Analytical Technology for your bioequivalence needs in China. Through these close strategic partnerships, we are able to offer a one-stop service which allows pharmaceutical development, dissolution profiling, stability studies, bio-equivalence studies, testing of plasma samples and commercial manufacture. Having these integrated services ensures the success of your projects, shortens the time taken for R&D and keeps your project cost-effective. The integrated service is particularly attractive for clients that want to develop products for the Chinese domestic market or for both the Chinese and European markets.